This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1995 Oct;154(4):1348-50.

doi: 10.1016/s0022-5347(01)66858-7.

"Wildcatting" for breakthroughs in urothelial cancer detection and management--a frustrating business

PMID: 7544837
DOI: 10.1016/s0022-5347(01)66858-7

Editorial

"Wildcatting" for breakthroughs in urothelial cancer detection and management--a frustrating business

P J Walther. J Urol. 1995 Oct.

. 1995 Oct;154(4):1348-50.

doi: 10.1016/s0022-5347(01)66858-7.

Author

PMID: 7544837
DOI: 10.1016/s0022-5347(01)66858-7

No abstract available

PubMed Disclaimer

Comment on

Histopathological features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of the renal pelvis.
Terrell RB, Cheville JC, See WA, Cohen MB. Terrell RB, et al. J Urol. 1995 Oct;154(4):1342-7. J Urol. 1995. PMID: 7544836
Urinary beta-glucuronidase in screening and followup of primary urinary tract malignancy.
Ho KJ. Ho KJ. J Urol. 1995 Oct;154(4):1335-8. J Urol. 1995. PMID: 7658533 Clinical Trial.
Integral photodynamic treatment of refractory superficial bladder cancer.
Kriegmair M, Waidelich R, Lumper W, Ehsan A, Baumgartner R, Hofstetter A. Kriegmair M, et al. J Urol. 1995 Oct;154(4):1339-41. J Urol. 1995. PMID: 7658534 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information